BBVA
GTHX

Banco Bilbao Vizcaya Argentaria’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-25,940
Closed -$629K – 774
2020
Q2 		$629K Buy
+25,940
New +$429K 0.02% 509

Other funds holding GTHX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's GTHX Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2020, closing a stake of 25,940 shares — an estimated $629K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in GTHX in Q2 2020 and held it in 1 quarter. The position peaked at $629K in Q2 2020. 118 funds tracked by Wall St. Rank hold GTHX as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 25,940 G1 Therapeutics, Inc. Common Stock shares in Q3 2020, an estimated $629K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Banco Bilbao Vizcaya Argentaria's G1 Therapeutics, Inc. Common Stock position peaked at $629K in Q2 2020.
  • 118 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.